Genevieve Boland MD, PhD:
What’s unique about the research environment at the Mass General is that we’re a true general hospital so we have expertise across a whole variety of specialties. However there is a very, very deep academic foundation in the research community so we can cross-fertilize across a lot of different groups and a lot of different types of expertise and it’s really exciting to do research here.

Gary Tearney, MD, PhD:
I love everything about my job here at Mass General. I wake up in the morning and I’m dying to come to work to come up with new discoveries that can help patients.

Anna Mandinova, PhD:
I love starting with a crazy idea, thinking that that’s absolutely science fiction, and step by step realizing that actually we can do it.

Matthew Rosen, PhD:
As an experimental physicist I could have stayed in my basement laboratory just tinkering and developing tools. But here at Mass General Hospital I’m able to make real impact with these tools, working with clinician scientists and solving real problems that are relevant for medical care.

Ghazaleh Sadri-Vakili, PhD:
The energy that the people have and what they bring to what they’re doing here is contagious and it’s just an honor and pleasure to be around.

Susan Slaugenhaupt, PhD:
The Mass General Research Institute was established to guide, promote, and support all research at Mass General. One of the overarching goals of the Mass General Research Institute is to raise unrestricted funds for our investigators through philanthropy.

Harry Orf, PhD:
Another goal of the research institute was to diversify our funding portfolio and make sure that we did not rely on a single source such as the federal government for our funding.

Maurizio Fava, MD:
We created a Division of Clinical Research to really allow for the highlighting of clinical research at this institution.

Harry Orf:
The final goal of the research institute was to form a partnership with our patients to help further research and development in the areas of personalized medicine.

Susan Slaugenhaupt:
After five years, we’re starting to see some of our efforts come to fruition. Since its inception, we’ve named 65 MGH research scholars, and this has provided $500,000.00 to each of these scholars raised through philanthropy to support the next great idea.

Anne Clancy, PhD:
The Mass General Research Institute has really changed how the outside regulatory agencies view us. So instead of this very complex widespread disparate group of people, they really see us as a unit all working together with a common goal.

Gaurdia Banister PhD, RN:
Its incredible infrastructure of services and programs that it offers that we have been able to take advantage of. Our nurse scientists have been incredibly valuable.

Mason Freeman, MD:
We’ve been doing translational research at Mass General for many, many, many years. But what we didn’t have was a focused, concerted effort and an up to date research facility where we could bring study subjects in and study the latest advances in medical technology and new drugs in a very highly controlled experimental way.

Ghazaleh Sadri-Vakili:
I love the Research Institute’s strategic alliances [initiative]. I think that’s been really helpful in bringing us closer with industry partners and showcasing our work and research and just really promoting it both within the hospital and outside the hospital as well.

Susan Slaugenhaupt:
Over the next five years, the research institute must focus on continuing to raise unrestricted support for our investigators at Mass General.

Harry Orf:
I’d also like to see a continuous effort to review our space needs, particularly in the area of wet space, so that our expansion and our resources that support it can keep up with the rapidly developing program we’re experiencing in our research enterprise.

Maurizio Fava:
We have absolutely amazing fundamental researchers and we want them to be more and more engaged with our clinical  investigators.

Gabriela Apiou, PhD:
Our goal is to train all our faculty to translate their amazing research into practical solutions that improve patient’s life.

Efren Flores, MD:
And where I see this research institution going is into an environment where everyone has an opportunity to participate in research as a window to get better clinical care.

Joseph Betancourt, MD, MPH:
The opportunities for research to identify and adjust disparities are limitless and I strongly believe that Mass General Hospital and our work here over the last five years and into the future can make an incredible difference.

Susan Slaugenhaupt:
As the scientific director of the Mass General Research Institute, the one thing that I want all of our investigators at Mass General to know is that you are part of the research institute, you are what makes this institute strong, you are what makes us what we are, and you are the Mass General Research Institute.

Matthew Rosen: I’m Matt and I am the Mass General Research Institute.

Hanna Gaggin, MD, MPH: I am Hanna and I am the Mass General Research Institute.

Donna Lawson: I am Donna and I am the Mass General Research Institute.

Miriam Bredella, MD: I am Miriam.

Gaurdia Banister: I am Gaurdia.

Gabriela Apiou: I am Gabriela.

Bob Kingston, PhD: I am Bob.

George Alba, MD: I am George.

Susan Slaugenhaupt: I am Sue.

Gary Tearney: My name is Gary.

Nitya Jain, PhD: My name is Nitya.

Anna Mandinova: My name is Anna.

Margarita Alegria, PhD: My name is Margarita.

Shannon Stott, PhD: My name is Shannon.

Joseph Betancourt: My name is Joe.

Ghazaleh Sadri-Vakili: My name is Ghazaleh.

Harry Orf: I’m Harry.

Efren Flores: I’m Efren.

Maurizio Fava: I’m Maurizio.

Genevieve Boland: I am Genevieve.

Anne Clancy: I am Anne.

Mason Freeman: I am Mason.

Steve Bartels, MD: I am Steve.

Marcia Goldberg, MD: I am Marcia and I am the Mass General Research Institute.